P14151 (LYAM1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 144.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: L-selectin Alternative name(s): CD62 antigen-like family member L Leukocyte adhesion molecule 1 Short name=LAM-1 Leukocyte surface antigen Leu-8 Leukocyte-endothelial cell adhesion molecule 1 Short name=LECAM1 Lymph node homing receptor TQ1 gp90-MEL CD_antigen=CD62L | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 372 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Cell surface adhesion protein. Mediates the adherence of lymphocytes to endothelial cells of high endothelial venules in peripheral lymph nodes. Promotes initial tethering and rolling of leukocytes in endothelia. Ref.10 |
| Subunit structure | Interaction with PSGL1/SELPLG and PODXL2 is required for promoting recruitment and rolling of leukocytes. This interaction is dependent on the sialyl Lewis X glycan modification of PSGL1 and PODXL2, and tyrosine sulfation modifications of PSGL1. Sulfation on Y-51 of PSGL1 is important for L-selectin binding. |
| Subcellular location | |
| Tissue specificity | Expressed in B cell lines and T lymphocytes. Ref.2 |
| Sequence similarities | Belongs to the selectin/LECAM family. Contains 1 C-type lectin domain. Contains 1 EGF-like domain. Contains 2 Sushi (CCP/SCR) domains. |
| Sequence caution | The sequence CAA34203.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened. The sequence CAB43536.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened. The sequence CAB43537.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Cell adhesion |
| Cellular component | Membrane |
| Coding sequence diversity | Polymorphism |
| Domain | EGF-like domain Repeat Signal Sushi Transmembrane Transmembrane helix |
| Ligand | Lectin |
| PTM | Disulfide bond Glycoprotein |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological process | blood coagulation Traceable author statement. Source: Reactome cell adhesionTraceable author statement. Source: ProtInc leukocyte migrationTraceable author statement. Source: Reactome regulation of immune responseTraceable author statement. Source: Reactome |
| Cellular component | integral to plasma membrane Traceable author statement. Source: ProtInc |
| Molecular function | glycosphingolipid binding Traceable author statement. Source: BHF-UCL heparin bindingTraceable author statement. Source: BHF-UCL protease bindingInferred from physical interaction. Source: BHF-UCL sugar bindingInferred from electronic annotation. Source: UniProtKB-KW |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 28 | 28 | |||||||||||||||||||||||||||||||||||||
| Propeptide | 29 – 38 | 10 | PRO_0000017475 | ||||||||||||||||||||||||||||||||||||
| Chain | 39 – 372 | 334 | L-selectin | PRO_0000017476 | |||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||
| Topological domain | 39 – 332 | 294 | Extracellular Potential | ||||||||||||||||||||||||||||||||||||
| Transmembrane | 333 – 355 | 23 | Helical; Potential | ||||||||||||||||||||||||||||||||||||
| Topological domain | 356 – 372 | 17 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||||||
| Domain | 55 – 155 | 101 | C-type lectin | ||||||||||||||||||||||||||||||||||||
| Domain | 156 – 192 | 37 | EGF-like | ||||||||||||||||||||||||||||||||||||
| Domain | 195 – 256 | 62 | Sushi 1 | ||||||||||||||||||||||||||||||||||||
| Domain | 257 – 318 | 62 | Sushi 2 | ||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||
| Glycosylation | 60 | 1 | N-linked (GlcNAc...) Ref.9 Ref.13 | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 104 | 1 | N-linked (GlcNAc...) Ref.13 | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 177 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 232 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 246 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 271 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Glycosylation | 311 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||
| Disulfide bond | 57 ↔ 155 | By similarity | |||||||||||||||||||||||||||||||||||||
| Disulfide bond | 128 ↔ 147 | By similarity | |||||||||||||||||||||||||||||||||||||
| Disulfide bond | 160 ↔ 171 | By similarity | |||||||||||||||||||||||||||||||||||||
| Disulfide bond | 165 ↔ 180 | By similarity | |||||||||||||||||||||||||||||||||||||
| Disulfide bond | 182 ↔ 191 | By similarity | |||||||||||||||||||||||||||||||||||||
| Disulfide bond | 197 ↔ 241 | By similarity | |||||||||||||||||||||||||||||||||||||
| Disulfide bond | 227 ↔ 254 | By similarity | |||||||||||||||||||||||||||||||||||||
| Disulfide bond | 259 ↔ 303 | By similarity | |||||||||||||||||||||||||||||||||||||
| Disulfide bond | 289 ↔ 316 | By similarity | |||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 193 | 1 | F → L. Ref.1 Ref.4 Ref.7 Corresponds to variant rs1131498 [ dbSNP | Ensembl ]. | VAR_019134 | |||||||||||||||||||||||||||||||||||
| Natural variant | 201 | 1 | E → Q. Ref.7 Corresponds to variant rs2229568 [ dbSNP | Ensembl ]. | VAR_019135 | |||||||||||||||||||||||||||||||||||
| Natural variant | 213 | 1 | P → S. Ref.3 Ref.7 Corresponds to variant rs2229569 [ dbSNP | Ensembl ]. | VAR_019136 | |||||||||||||||||||||||||||||||||||
| Natural variant | 369 | 1 | N → D. Ref.7 Corresponds to variant rs4987382 [ dbSNP | Ensembl ]. | VAR_019137 | |||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 37 | 1 | D → Y in CAA34203. Ref.4 | ||||||||||||||||||||||||||||||||||||
| Sequence conflict | 178 | 1 | Y → H in CAA34203. Ref.4 | ||||||||||||||||||||||||||||||||||||
| Sequence conflict | 214 | 1 | L → F in CAA34203. Ref.4 | ||||||||||||||||||||||||||||||||||||
| Sequence conflict | 218 – 220 | 3 | SFS → NFN in CAA34275. Ref.2 | ||||||||||||||||||||||||||||||||||||
| Sequence conflict | 242 | 1 | G → E in CAA34275. Ref.2 | ||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 40 – 48 | 9 | |||||||||||||||||||||||||||||||||||||
| Helix | 50 – 60 | 11 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 61 – 64 | 4 | |||||||||||||||||||||||||||||||||||||
| Helix | 70 – 79 | 10 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 87 – 94 | 8 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 97 – 100 | 4 | |||||||||||||||||||||||||||||||||||||
| Turn | 101 – 103 | 3 | |||||||||||||||||||||||||||||||||||||
| Turn | 109 – 111 | 3 | |||||||||||||||||||||||||||||||||||||
| Helix | 122 – 124 | 3 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 128 – 131 | 4 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 136 – 138 | 3 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 142 – 145 | 4 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 151 – 157 | 7 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 167 – 174 | 8 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 177 – 182 | 6 | |||||||||||||||||||||||||||||||||||||
| Beta strand | 187 – 191 | 5 | |||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Human homologue of mouse lymph node homing receptor: evolutionary conservation at tandem cell interaction domains." Siegelman M.H., Weissman I.L. Proc. Natl. Acad. Sci. U.S.A. 86:5562-5566(1989) [PubMed: 2664786] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANT LEU-193. Tissue: Lymphocyte. |
| [2] | "Isolation and chromosomal localization of cDNAs encoding a novel human lymphocyte cell surface molecule, LAM-1. Homology with the mouse lymphocyte homing receptor and other human adhesion proteins." Tedder T.F., Isaacs C.M., Ernst T.J., Demetri G.D., Adler D.A., Disteche C.M. J. Exp. Med. 170:123-133(1989) [PubMed: 2473156] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY. Tissue: Tonsil. |
| [3] | "Leu-8/TQ1 is the human equivalent of the Mel-14 lymph node homing receptor." Camerini D., James S.P., Stamenkovic I., Seed B. Nature 342:78-82(1989) [PubMed: 2509939] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANT SER-213. Tissue: Lymphocyte. |
| [4] | "Characterization of a human homologue of the murine peripheral lymph node homing receptor." Bowen B.R., Nguyen T., Lasky L.A. J. Cell Biol. 109:421-427(1989) [PubMed: 2663882] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANT LEU-193. Tissue: Lymphocyte. |
| [5] | "Structure of the gene encoding the human leukocyte adhesion molecule-1 (TQ1, Leu-8) of lymphocytes and neutrophils." Ord D.C., Ernst T.J., Zhou L.J., Rambaldi A., Spertini O., Griffin J., Tedder T.F. J. Biol. Chem. 265:7760-7767(1990) [PubMed: 1692315] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [6] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [7] | SeattleSNPs variation discovery resource Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS LEU-193; GLN-201; SER-213 AND ASP-369. |
| [8] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed: 16710414] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [9] | "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry." Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., Smith R.D. J. Proteome Res. 4:2070-2080(2005) [PubMed: 16335952] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-60, MASS SPECTROMETRY. Tissue: Plasma. |
| [10] | "Molecular basis of leukocyte rolling on PSGL-1. Predominant role of core-2 O-glycans and of tyrosine sulfate residue 51." Bernimoulin M.P., Zeng X.-L., Abbal C., Giraud S., Martinez M., Michielin O., Schapira M., Spertini O. J. Biol. Chem. 278:37-47(2003) [PubMed: 12403782] [Abstract] Cited for: INTERACTION WITH SELPLG, FUNCTION. |
| [11] | "Model glycosulfopeptides from P-selectin glycoprotein ligand-1 require tyrosine sulfation and a core 2-branched O-glycan to bind to L-selectin." Leppaenen A., Yago T., Otto V.I., McEver R.P., Cummings R.D. J. Biol. Chem. 278:26391-26400(2003) [PubMed: 12736247] [Abstract] Cited for: INTERACTION WITH SELPLG. |
| [12] | "Endoglycan, a member of the CD34 family of sialomucins, is a ligand for the vascular selectins." Kerr S.C., Fieger C.B., Snapp K.R., Rosen S.D. J. Immunol. 181:1480-1490(2008) [PubMed: 18606703] [Abstract] Cited for: INTERACTION WITH PODXL2. |
| [13] | "Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins." Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M., Schiess R., Aebersold R., Watts J.D. Nat. Biotechnol. 27:378-386(2009) [PubMed: 19349973] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-60 AND ASN-104, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [14] | "A template for generation and comparison of three-dimensional selectin models." Bajorath J., Aruffo A. Biochem. Biophys. Res. Commun. 216:1018-1023(1995) [PubMed: 7488174] [Abstract] Cited for: 3D-STRUCTURE MODELING. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M25280 mRNA. Translation: AAC63053.1. X16150 mRNA. Translation: CAA34275.1. X17519 mRNA. Translation: CAB43536.1. Different initiation. X17519 mRNA. Translation: CAB43537.1. Different initiation. X16070 mRNA. Translation: CAA34203.1. Different initiation. M32414 M32413 Genomic DNA. Translation: AAB60700.1.AK312673 mRNA. Translation: BAG35555.1. AY233976 Genomic DNA. Translation: AAO48272.1. AL021940 Genomic DNA. No translation available. | ||||||||||||||||||
| IPI | IPI00218795. | ||||||||||||||||||
| RefSeq | NP_000646.2. NM_000655.4. | ||||||||||||||||||
| UniGene | Hs.728756. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | P14151. | ||||||||||||||||||
| SMR | P14151. Positions 39-350. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| STRING | P14151. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| GlycoSuiteDB | P14151. | ||||||||||||||||||
Polymorphism databases | |||||||||||||||||||
| DMDM | 126178. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PRIDE | P14151. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000236147; ENSP00000236147; ENSG00000188404. | ||||||||||||||||||
| GeneID | 6402. | ||||||||||||||||||
| KEGG | hsa:6402. | ||||||||||||||||||
| UCSC | uc001ggk.1. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 6402. | ||||||||||||||||||
| GeneCards | GC01M169659. | ||||||||||||||||||
| H-InvDB | HIX0199982. | ||||||||||||||||||
| HGNC | HGNC:10720. SELL. | ||||||||||||||||||
| HPA | CAB002144. | ||||||||||||||||||
| MIM | 153240. gene. | ||||||||||||||||||
| neXtProt | NX_P14151. | ||||||||||||||||||
| Orphanet | 34145. Berger disease. | ||||||||||||||||||
| PharmGKB | PA35642. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | prNOG05451. | ||||||||||||||||||
| HOVERGEN | HBG052375. | ||||||||||||||||||
| InParanoid | P14151. | ||||||||||||||||||
| OrthoDB | EOG4FFD22. | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| Reactome | REACT_604. Hemostasis. REACT_6900. Immune System. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | P14151. | ||||||||||||||||||
| Bgee | P14151. | ||||||||||||||||||
| CleanEx | HS_SELL. | ||||||||||||||||||
| Genevestigator | P14151. | ||||||||||||||||||
| GermOnline | ENSG00000188404. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR001304. C-type_lectin. IPR016186. C-type_lectin-like. IPR018378. C-type_lectin_CS. IPR016187. C-type_lectin_fold. IPR016060. Complement_control_module. IPR006209. EGF. IPR006210. EGF-like. IPR013032. EGF-like_reg_CS. IPR000742. EGF_3. IPR016348. L-selectin. IPR002396. Selectin_superfamily. IPR000436. Sushi_SCR_CCP. [Graphical view] | ||||||||||||||||||
| Gene3D | G3DSA:3.10.100.10. C-type_lectin-like. 1 hit. G3DSA:2.10.70.10. Complement_control_module. 2 hits. | ||||||||||||||||||
| KO | K06495. | ||||||||||||||||||
| PANTHER | PTHR19325:SF20. PTHR19325:SF20. 1 hit. | ||||||||||||||||||
| Pfam | PF00008. EGF. 1 hit. PF00059. Lectin_C. 1 hit. PF00084. Sushi. 2 hits. [Graphical view] | ||||||||||||||||||
| PIRSF | PIRSF002421. L-selectin. 1 hit. | ||||||||||||||||||
| PRINTS | PR00343. SELECTIN. | ||||||||||||||||||
| SMART | SM00032. CCP. 2 hits. SM00034. CLECT. 1 hit. SM00181. EGF. 1 hit. [Graphical view] | ||||||||||||||||||
| SUPFAM | SSF56436. C-type_lectin_fold. 1 hit. SSF57535. Complement_control_module. 2 hits. | ||||||||||||||||||
| PROSITE | PS00615. C_TYPE_LECTIN_1. 1 hit. PS50041. C_TYPE_LECTIN_2. 1 hit. PS00022. EGF_1. 1 hit. PS01186. EGF_2. 1 hit. PS50026. EGF_3. 1 hit. PS50923. SUSHI. 2 hits. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| NextBio | 24874. | ||||||||||||||||||
| PMAP-CutDB | P14151. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | LYAM1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P14151 Secondary accession number(s): B2R6Q8, P15023 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human cell differentiation molecules CD nomenclature of surface proteins of human leucocytes and list of entries |
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with